SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-060951
Filing Date
2018-02-27
Accepted
2018-02-27 16:36:15
Documents
69
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d530534d10k.htm 10-K 973311
2 EX-23.1 d530534dex231.htm EX-23.1 2488
3 EX-31.1 d530534dex311.htm EX-31.1 9815
4 EX-31.2 d530534dex312.htm EX-31.2 9643
5 EX-32.1 d530534dex321.htm EX-32.1 6081
12 GRAPHIC g530534g55s30.jpg GRAPHIC 63548
  Complete submission text file 0001193125-18-060951.txt   6756640

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20171231.xml EX-101.INS 1665815
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20171231.xsd EX-101.SCH 55788
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20171231_cal.xml EX-101.CAL 53469
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20171231_def.xml EX-101.DEF 413664
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20171231_lab.xml EX-101.LAB 397426
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20171231_pre.xml EX-101.PRE 440782
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 18645622
SIC: 2834 Pharmaceutical Preparations